{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:04:43Z","timestamp":1747188283125,"version":"3.40.5"},"reference-count":54,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Use of extracorporeal membrane oxygenation (ECMO) is increasing among critically ill adults with cardiac and\/or respiratory failure. Use of ECMO is associated with hemostatic alterations requiring use of anticoagulation and blood product support. There are limited guidelines to direct transfusion management in the adult patient supported with ECMO. The objective of this article is to describe (1) the role of the transfusion service in providing transfusion support and current understanding of transfusion thresholds, (2) the complexities of monitoring anticoagulation, and (3) the consideration regarding additional factor concentrates and antifibrinolytics within the context of ECMO support. The information provided should assist ECMO care teams in informing transfusion and anticoagulation practice while highlighting key areas for future research and collaboration.<\/jats:p>","DOI":"10.1111\/trf.16830","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T12:18:57Z","timestamp":1645013937000},"page":"741-750","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["How we manage blood product support and coagulation in the adult patient requiring extracorporeal membrane oxygenation"],"prefix":"10.1111","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-5139","authenticated-orcid":false,"given":"Daniel P.","family":"Kelly","sequence":"first","affiliation":[{"name":"Division of Medical Critical Care, Department of Pediatrics Boston Children's Hospital  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Wilson","family":"Grandin","sequence":"additional","affiliation":[{"name":"Division of Cardiology Beth Israel Deaconess Medical Center  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2579-8640","authenticated-orcid":false,"given":"Kerry L.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine Beth Israel Deaconess Medical Center  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000863"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000115"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199307000-00018"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12963"},{"key":"e_1_2_8_6_1","unstructured":"ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization Version 1.4. August 2017. Ann Arbor. Available from:www.elso.org"},{"key":"e_1_2_8_7_1","unstructured":"ELSO Anticoagulation Guideline Extracorporeal Life Support Organization August 2014. Ann Arbor. Available from:www.elso.org"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000345"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000439"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.09.004"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06593-x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000278"},{"issue":"4","key":"e_1_2_8_13_1","first-page":"S494","article-title":"Risk factors for bleeding and thrombosis events on veno\u2010arterial extracorporeal life support: an ELSO analysis","volume":"38","author":"Cabezas FR","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2016.07.005"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0267659112457969"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e31827127e4"},{"volume-title":"Technical manual","year":"2017","author":"Fung MK","key":"e_1_2_8_17_1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/aor.12385"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000002238"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.08.039"},{"volume-title":"Standards for blood banks and transfusion services","year":"2014","author":"Levitt J","key":"e_1_2_8_21_1"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000955"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.2011.01384.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000806"},{"key":"e_1_2_8_25_1","unstructured":"Thrombate III\u00ae.Antithrombin III (Human)[ package insert]. Research Triangle Park NC: Grifols Therapeutics Inc; 2016."},{"key":"e_1_2_8_26_1","unstructured":"ATryn\u00ae.Antithrombin(Recombinant) [package insert]. Framingham MA: rEVO Biologics Inc; 2013."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.036"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617693941"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2104091"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(03)00270-7"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(98)90591-7"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2016.01.011"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3182a443e8"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606424"},{"issue":"7","key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/CCM.0000000000004944","article-title":"Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: heparin versus bivalirudin","volume":"49","author":"Rivosecchi RM","year":"2021","journal-title":"Crit Care Med"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066616656333"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000691"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005033"},{"key":"e_1_2_8_39_1","unstructured":"Novo Nordisk A\/S.NovoSeven\u00aeRT Coagulation Factor VIIa (Recombinant)[ package insert]. Bagsvaerd (Denmark): Novo Nordisk A\/S; 2015."},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.3.293"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000525"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc12581"},{"issue":"3","key":"e_1_2_8_43_1","first-page":"CD005011","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Simpson E","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_44_1","unstructured":"Kcentra\u00ae.Prothrombin complex concentrate (human) [package insert]. Kankakee IL; 2017."},{"key":"e_1_2_8_45_1","first-page":"130","volume-title":"An algorithmic approach to hemostasis testing","author":"Kotte\u2010Marchant K","year":"2008"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.09.054"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2014.06.006"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16071"},{"issue":"2","key":"e_1_2_8_49_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1051\/ject\/200739081","article-title":"Heparin monitoring during cardiopulmonary bypass surgery using the one\u2010step point\u2010of\u2010care whole blood anti\u2010factor\u2010Xa clotting assay heptest\u2010POC\u2010Hi","volume":"39","author":"Hellstern P","year":"2007","journal-title":"J Extra Corpor Technol"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-010-0546-5"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1599153"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.03.85"},{"issue":"3","key":"e_1_2_8_53_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1051\/ject\/201850149","article-title":"Use of thromboelastography to predict thrombotic complications in pediatric and neonatal extracorporeal membranous oxygenation","volume":"50","author":"Henderson N","year":"2018","journal-title":"J Extra Corpor Technol"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0352-8"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3an00401e"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16830","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.16830","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.16830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T08:59:40Z","timestamp":1692953980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.16830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/trf.16830"],"URL":"https:\/\/doi.org\/10.1111\/trf.16830","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"type":"print","value":"0041-1132"},{"type":"electronic","value":"1537-2995"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"2019-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}